Questions? Call us at 800-810-7790
Jun 26, 2024

Weight Loss

Ozempic Babies: Is It a Myth?

Ozempic (semaglutide) is a medication for treatment of type 2 diabetes. It belongs to a drug class known as GLP-1 receptor agonists. These medications mimic the action of a hormone known as GLP-1, which tells your body to produce more insulin after a meal, slow emptying of your stomach, and suppress your appetite. GLP-1s are particularly desirable because they work best when your blood sugar is high and have less effect when your blood sugar is low, making them safer than other medications like sulfonylureas and insulin.

Ozempic has gained popularity for its known side effect: weight loss. Due to the link between obesity and type 2 diabetes, this side effect has become desirable and has led to a major increase in the medication use.

Reports of Pregnancy and Ozempic Use

Recently, a discussion has emerged on social media about the impact of Ozempic on fertility. Personal stories have surfaced from individuals who report unexpected pregnancies while taking Ozempic, despite using contraception like birth control pills.

Some people have shared that they conceived after years of infertility only after starting Ozempic. These unexpected pregnancies have led to the term "Ozempic babies." This raises the question: Could the use of Ozempic actually be linked to increased fertility or unexpected pregnancies?

Research on Ozempic and Oral Contraceptive Pills

Ozempic is known to slow down stomach emptying. This effect could potentially alter the absorption of medications taken orally, including birth control pills.

Unexpected pregnancies reported by individuals using both Ozempic and oral contraceptives could be due to several factors. While no birth control method is 100% effective, some concerns have been raised about whether Ozempic might reduce the effectiveness of oral contraceptives by affecting their absorption.

Fortunately, some research has been conducted on this topic. A study from 2015, conducted before the recent rise in reports of "Ozempic babies," explored the potential impact of semaglutide (the active ingredient in Ozempic) on the levels of oral contraceptives in the body. This study found that while there was a slight delay in reaching the maximum concentration of the contraceptive hormones—consistent with delayed stomach emptying—the overall levels of the oral contraceptives in the body were not reduced. The study concluded that using semaglutide should not decrease the effectiveness of oral contraceptive pills.

However, it's important to note some limitations of this study, such as the absence of a control group for comparison. While the study provides some evidence against the theory that Ozempic may reduce the effectiveness of oral birth control, more comprehensive research is needed to draw a firm conclusion.

Ozempic's Effects on Infertility

Another aspect of the conversation around Ozempic and fertility involves reports of increased pregnancies among individuals who previously experienced infertility. While anecdotal reports are noteworthy, they don't offer sufficient evidence to draw definitive conclusions.

To address this, an analysis of 11 studies conducted in 2023 focused on individuals with polycystic ovarian syndrome (PCOS), a condition affecting up to 1 in 5 women of reproductive age and a leading cause of infertility. PCOS is associated with dysfunctional ovulation, obesity, insulin resistance, and impaired blood sugar control. These factors can hinder regular ovulation and increase the risk of type 2 diabetes.

The analysis included only women diagnosed with PCOS and compared pregnancy rates between those treated with GLP-1 receptor agonists and those who were not. The findings revealed improved menstrual regularity and significantly higher fertility rates, as measured by an increase in natural pregnancies, in individuals treated with GLP-1 receptor agonists.

While this study alone cannot definitively prove that Ozempic increases fertility in those with a history of infertility, it provides supporting evidence for this possibility. Further research is needed to establish a clearer understanding of the relationship between Ozempic and fertility improvements in individuals with PCOS.

Mechanism of Ozempic's Effects on Infertility

Why might GLP-1 receptor agonists like Ozempic impact fertility, especially in those with PCOS? The answer likely lies in the metabolic and hormonal aspects of the condition.

The most plausible explanation is the effect of Ozempic on obesity. Obesity is a significant contributing factor to infertility, and the weight loss effects of Ozempic can lead to improved menstrual cycle regulation. Additionally, the hormonal changes induced by Ozempic may further enhance fertility.

Overall, the use of Ozempic can help women with PCOS begin menstruating regularly again, thus enabling pregnancy to occur. This phenomenon is not entirely unprecedented. Another diabetes medication, metformin, is frequently used to help with fertility in women with PCOS, even though this is not an approved indication for either medication.

While the precise mechanisms are still being studied, the potential benefits of Ozempic in improving fertility among women with PCOS are becoming increasingly evident. Further research will help clarify these effects and potentially broaden the use of such medications in treating infertility.

Is Ozempic Safe During Pregnancy?

If you are pregnant or planning to become pregnant, it is crucial to discuss your medications with your healthcare provider. This ensures you understand which medications are safe to continue throughout pregnancy and breastfeeding.

The safety of using Ozempic during pregnancy is uncertain, as pregnant individuals were excluded from clinical trials. Animal studies suggest that there may be some risk to the fetus when exposed to Ozempic during pregnancy. Consequently, the current recommendation is to discontinue Ozempic at least two months before a planned pregnancy to allow the medication to be fully cleared from the system.

However, it's important not to stop taking Ozempic without consulting your healthcare provider. Uncontrolled diabetes poses significant risks to both the mother and fetus during pregnancy. If a pregnancy occurs while on Ozempic, there are other medications with known safety profiles, such as insulin, that can be used to manage type 2 diabetes during pregnancy.

Always seek professional medical advice to ensure the health and safety of both you and your baby when considering medication use during pregnancy.

Summary: Does Ozempic Improve Fertility?

In summary, there is no definitive answer to whether Ozempic increases fertility. Current data suggest that Ozempic does not decrease the effectiveness of oral contraceptives. On the contrary, there is evidence that Ozempic may improve fertility in women with PCOS-related infertility. However, more research is needed to reach a clear conclusion.

The safety of Ozempic during pregnancy is also not well understood. Current recommendations advise discontinuing Ozempic at least two months before conception to ensure the medication is fully cleared from the system.

If you have any concerns about using Ozempic while on oral contraceptives or when trying to conceive, whether you have PCOS or not, it is essential to speak with your healthcare provider. They can provide personalized advice and guidance based on your specific situation.


  1. OZEMPIC (semaglutide) injection, for subcutaneous use. Food and Drug Administration. (2017; revised 03/2022). Retrieved Jun 9, 2024, from
  2. Nancy Schimelpfening. (2024, March 26). 'Ozempic Babies': How Weight Loss Drugs Can Interfere with Birth Control and Boost Fertility. Healthline.
  3. Kapitza, C., Nosek, L., Jensen, L., Hartvig, H., Jensen, C. B., & Flint, A. (2015). Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel. The Journal of Clinical Pharmacology, 55(5), 497–504.
  4. Zhou, L., Qu, H., Yang, L., & Shou, L. (2023). Effects of GLP1RAs on pregnancy rate and menstrual cyclicity in women with polycystic ovary syndrome: a meta-analysis and systematic review. BMC Endocrine Disorders, 23(1).
  5. Szczesnowicz, A., Szeliga, A., Niwczyk, O., Bala, G., & Meczekalski, B. (2023). Do GLP-1 Analogs Have a Place in the Treatment of PCOS? New Insights and Promising Therapies. ProQuest, 12(18), 5915.

Related posts

Alli - An OTC medication for Weight Loss

Which Prescription Drugs Are Approved for Weight Loss?

What Is The Healthy Way to Lose Weight?